South & Central America Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type (Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy & Stromal Vascular Fraction, Prolotherapy, and Others), Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot & Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), and End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others)
The South & Central America osteoarthritis therapy market was valued at US$ 345.44 million in 2022 and is expected to reach US$ 552.40 million by 2030; it is estimated to register a CAGR of 6.0% from 2022 to 2030.
More Effective Treatment Options Fuels South & Central America Osteoarthritis Therapy Market
Currently, there is no cure for OA. A group of clinical research scientists, through clinical trials, reveal that they are developing innovative treatment target options that can stop the progression of OA. For example, in November 2021, LG Chem company announced the initiation of a clinical trial for next-generation new drugs to treat arthritis. Additionally, in October 2021, Pacira BioSciences, Inc. announced the acquisition of Flexion Therapeutics to treat non-opioid pain management "ZILRETTA". The drug approved in 2017 is the first and only approved treatment for OA knee pain utilizing extended-release microsphere technology.
In September 2023, Sorrento Therapeutics, Inc. announced positive Phase 2 top-line clinical trial results for the "Resiniferatoxin (RTX) program". The Phase 2 trial is a multi-center, double-blind, placebo, and active-controlled study assessing the efficacy and safety of several dose groups of RTX to manage pain in patients with moderate-to-severe OAK. Also, Sorrento decided to include an active approved competitor drug, "Zilretta," in the current clinical trial protocol.
South & Central America Osteoarthritis Therapy Market Overview
South & Central America countries comprises Brazil, Argentina, and Rest of South & Central America. The new product launches by the manufacturers to stay ahead in the competitive market is a significant factor responsible for market growth in South & Central America region. According to the Researchgate report, in Brazil, the prevalence of osteoarthritis is 33% among individuals over the age of 25, resulting in an estimated 40 million people suffering from the disorder. Additionally, the Korean Knee Society report reveals that osteoarthritis affects ~4% of the adult population in Brazil. The new product launches by the manufacturers to stay ahead in the competitive market is a significant factor responsible for market growth. For instance, in October 2018, Bioventus announced approval for "DUROLANE" from Agência Nacional de Vigilância Sanitária (ANVISA). The newly launched product is a single injection for OA treatment in Brazil. ANVISA approved DUROLANE for the symptomatic treatment of mild to moderate knee and hip OA. Therefore, innovative product launches in Brazil to treat osteoarthritis fuel the market growth.
South & Central America Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Osteoarthritis Therapy Market Segmentation
The South & Central America osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.
Based on therapy type, the South & Central America osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.
In terms of disease indications, the South & Central America osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of South & Central America in 2022.
Based on end user, the South & Central America osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of South & Central America in 2022.
By country, the South & Central America osteoarthritis therapy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America share in 2022.
Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, and Omron Healthcare Inc are some of the leading companies operating in the South & Central America osteoarthritis therapy market.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. South & Central America Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - South & Central America Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. South & Central America Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Osteoarthritis Therapy Market - Country Analysis
10.1 South & Central America Market Overview
10.1.1 South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Zimmer Biomet Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 DePuy Synthes Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Bioventus Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Omron Healthcare Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Organic Developments Done by Companies
Table 13. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. South & Central America: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. South & Central America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Osteoarthritis Therapy Market
1. Zimmer Biomet Holdings Inc
2. DePuy Synthes Inc
3. Bioventus Inc
4. Omron Healthcare Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.